Board Diversity Action Expands to Courtrooms, Regulators, and Investors
Harvard Corporate Governance
JULY 13, 2022
Posted by Matthew Fust, on Wednesday, July 13, 2022 Editor's Note: Matthew Fust serves as a board member for several publicly traded and venture-backed biopharmaceutical companies and is a corporate finance and strategy advisor in the life sciences industry. This post is based on an NACD BoardTalk publication. Related research from the Program on Corporate Governance includes Politics and Gender in the Executive Suite (discussed on the Forum here ) by Alma Cohen, Moshe Hazan, and David Weiss; W
Let's personalize your content